Skip to content

rTMS combined with rehabilitation for post-stroke hemiparesis : Evaluation by MRS

rTMS combined with rehabilitation for post-stroke hemiparesis : Evaluation by MRS - rTMS and rehabilitation therapy for hemiparesis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1090220226
Enrollment
40
Registered
2015-10-29
Start date
2015-11-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke hemiparesis

Interventions

Intervention type:BEHAVIOUR,DEVICE Name of intervention:rTMS combined with rehabilitation Dose form / Japanese Medical Device Nomenclature:DEVICE MagPro R30 Route of administration / Site of applicati

Sponsors

The Izumi memorial hospital
Lead Sponsor
The Jikei University School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Brunnstrom stage for hand-fingers of 4 or 5; (2) time between the onset of stroke and intervention of more than 12 months; (3) history of a single stroke only (no bilateral cerebrovascular lesion); (4) no cognitive impairment with a pretreatment MiniMental State Examination score of more than 26; (5) clinical confirmation of a plateau state, representing no score increase in the Fugl-Meyer Assessment (FMA) in the latest three months; (6) no pathological conditions known to be contraindications for rTMS in the guidelines suggested by Wassermann;

Exclusion criteria

Exclusion criteria: (1)active physical or mental illness requiring medical management; (2)history of seizure within one-year preceding theintervention; (3)documented epileptic discharge on pretreatmentelectroencephalogram; (4)current use of antiepileptic medications for the prevention of seizure;

Design outcomes

Primary

MeasureTime frame
efficacy

Secondary

MeasureTime frame
MRS and Fugl-Meyer Assessment

Countries

Japan

Contacts

Public ContactMasayoshi Minami

The Izumi memorial hospital

tealoop@gmail.com+81-3-5888-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026